Medicine Today
Internal Medicine Webcast Series
Statin Treatment in African
Americans: Is There a Case for a
Race-Based Approach?
Release Date: October 23, 2006
Renewal Date: October 25, 2008
Expiration Date: October 25, 2009
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Estimated Time of Completion: 1 hour
Description
The Medicine Today, Internal Medicine Webcast Series features on-demand CME webcasts. Each webcast consists of an hour-long video presentation and related questions following the video.
Upon completing the CME activity, the post-test, the evaluation and registration forms, you will have an opportunity to print your CME certificate for your records.
Throughout the interactive case-based lesson, you may proceed to the next question once you answer each question correctly. In addition to allowing you
to proceed, the correct answer also reveals the rationale for the answer.
Objectives
- Review the epidemiology of coronary heart disease (CHD) specifically related to African Americans.
- Discuss unique aspects of CHD risk factors for African Americans.
- Describe clinical evidence for lipid lowering in African Americans including the recent African American Rosuvastatin Investigation of Efficacy and Safety (ARIES) trial.
Target Audience
This activity is intended for general internists and subspecialists.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Director
William D. Carey, MD
Director, Center for Continuing Education
The Cleveland Clinic Foundation
Cleveland, Ohio
Author / Faculty
Keith C. Ferdinand, MD, FACC |
Faculty Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
William D. Carey, MD
The following faculty has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:
Keith C. Ferdinand, MD, FACC
Research - AstraZeneca, Merck, NitroMed, Novartis, Pfizer
Consultant - AstraZeneca, NitroMed, Novartis
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education.
